Discovery of Pyrroloaminopyrazoles as Novel PAK Inhibitors
Chuangxing Guo(Pfizer (United States)), Brion W. Murray(Pfizer (United States)), Djamal Bouzida(Pfizer (United States)), Junhu Zhang(Jilin University), Joseph Marakovits(Pfizer (United States)), Robert S. Kania(RG Biopharma (United States)), Liming Dong(Pfizer (United States)), Susan E. Kephart(Pfizer (United States)), Lisa Guo(Pfizer (United States)), Martin P. Edwards(Pfizer (United States)), Jayashree Tikhe(Pfizer (United States)), Tod Smeal(Pfizer (United States)), Eugenia Kraynov(Pfizer (United States)), Christine Del-Carmen(Pfizer (United States)), James G. Christensen, Eleanor Dagostino(Polaris (United States)), Anle Yang(Pfizer (United States)), Joseph Piraino(Pfizer (United States)), Joseph Lee(Pfizer (United States)), Haitao Li(King Center), Ya‐Li Deng(Pfizer (United States)), M. Catherine Johnson(Pfizer (United States)), Daniel Knighton(Pfizer (United States)), Indrawan McAlpine(Pfizer (United States)), Paul Richardson(Pfizer (United States))
Cited by 60
Related Papers
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The photoluminescence mechanism in carbon dots (graphene quantum dots, carbon nanodots, and polymer dots): current state and future perspective
|Nano Research|2015|2.7k
Surface Chemistry Routes to Modulate the Photoluminescence of Graphene Quantum Dots: From Fluorescence Mechanism to Up‐Conversion Bioimaging Applications
|Advanced Functional Materials|2012|1.1k
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
|Cancer Cell|2010|1.1k